The Sinopharm vaccine showed three times the death rate from breakthrough infections than the Pfizer-BioNTech vaccine, a Bahrain Study showed
using a different shot made by Pfizer Inc. and BioNTech SE . It now also offers booster shots for other vaccines.
The study, posted online this week ahead of peer review, shows that all the vaccines administered since December in the Persian Gulf island nation—which also include Covishield, an Indian-made version of AstraZeneca ’s vaccine, and the Russian-made Sputnik V—were effective in reducing severe illness compared to the unvaccinated population.
But the percentage of deaths among all PCR positive post-vaccination Covid-19 cases was 0.46% for Sinopharm recipients compared to 0.15% for Pfizer-BioNTech and 0.03% for AstraZeneca, the study showed. That trend was consistent for infection and hospitalization, even with the advent of the Delta variant. Sputnik V results were intermediate.
“They found that there is significant difference between hospitalization, ICU admission and death in favor of Pfizer compared to Sinopharm, especially in older populations and in the context of the emergence of the Delta variant,” said co-author Dr. Jaleela Al-Sayed Jawad.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid Infection Has ‘Much Higher’ Risk Of Blood Clots Than Vaccines Do, Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Weiterlesen »
Covid Infection Has ‘Much Higher’ Risk Of Blood Clots Than Vaccines Do, Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Weiterlesen »
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines PossibleCovid’s forgotten hero: The untold story of the scientist whose breakthrough made the vaccines possible:
Weiterlesen »
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines PossibleCovid’s forgotten hero: The untold story of the scientist whose breakthrough made the vaccines possible:
Weiterlesen »
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines PossibleCovid’s forgotten hero: The untold story of the scientist whose breakthrough made the vaccines possible:
Weiterlesen »
Long COVID's daunting toll seen in study of pandemic's earliest patientsA study of more than 1,200 COVID survivors who were once hospitalized finds that about half have at least one symptom a year later.
Weiterlesen »